6-124283055-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BA1
The NM_001040214.3(NKAIN2):āc.105A>Gā(p.Ala35=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00501 in 1,612,806 control chromosomes in the GnomAD database, including 256 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.022 ( 114 hom., cov: 32)
Exomes š: 0.0032 ( 142 hom. )
Consequence
NKAIN2
NM_001040214.3 synonymous
NM_001040214.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.27
Genes affected
NKAIN2 (HGNC:16443): (sodium/potassium transporting ATPase interacting 2) This gene encodes a transmembrane protein that interacts with the beta subunit of a sodium/potassium-transporting ATPase. A chromosomal translocation involving this gene is a cause of lymphoma. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 6-124283055-A-G is Benign according to our data. Variant chr6-124283055-A-G is described in ClinVar as [Benign]. Clinvar id is 776152.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=3.27 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0728 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NKAIN2 | NM_001040214.3 | c.105A>G | p.Ala35= | synonymous_variant | 2/7 | ENST00000368417.6 | NP_001035304.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NKAIN2 | ENST00000368417.6 | c.105A>G | p.Ala35= | synonymous_variant | 2/7 | 5 | NM_001040214.3 | ENSP00000357402 | P1 | |
NKAIN2 | ENST00000368416.5 | c.105A>G | p.Ala35= | synonymous_variant | 2/4 | 1 | ENSP00000357401 | |||
NKAIN2 | ENST00000476571.1 | n.229A>G | non_coding_transcript_exon_variant | 3/5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0224 AC: 3404AN: 152084Hom.: 114 Cov.: 32
GnomAD3 genomes
AF:
AC:
3404
AN:
152084
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00678 AC: 1705AN: 251364Hom.: 51 AF XY: 0.00505 AC XY: 686AN XY: 135854
GnomAD3 exomes
AF:
AC:
1705
AN:
251364
Hom.:
AF XY:
AC XY:
686
AN XY:
135854
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00319 AC: 4663AN: 1460604Hom.: 142 Cov.: 29 AF XY: 0.00286 AC XY: 2079AN XY: 726736
GnomAD4 exome
AF:
AC:
4663
AN:
1460604
Hom.:
Cov.:
29
AF XY:
AC XY:
2079
AN XY:
726736
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0225 AC: 3419AN: 152202Hom.: 114 Cov.: 32 AF XY: 0.0213 AC XY: 1584AN XY: 74420
GnomAD4 genome
AF:
AC:
3419
AN:
152202
Hom.:
Cov.:
32
AF XY:
AC XY:
1584
AN XY:
74420
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
20
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at